Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab - Dargaud, Y; Lienhart, A; Janbain, M; Le Quellec, S; Enjolras, N; Negrier, C (Haematologica, 2018)